EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies

Jun Liao, Wenxiu He, Lisha Li, Jingya Wang, Lidong Gong, Qiang Zhang, Zhiqiang Lin

Cell Biomaterials · 2025-03 · 1 (2) · 100016

DOI: 10.1016/j.celbio.2025.100016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biomaterials, 2025-03. Verfasst von Jun Liao und 6 weiteren Autor:innen. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 542 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality, Beijing Natural Science Foundation, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria, as central regulators of cell fate, signaling, metabolism, and tissue homeostasis, are critical in the pathogenesis of brain diseases. Recent advancements in nanomedicine delivery technologies have elucidated mitochondrial heterogeneity, intercellular interactions, and downstream therapeutic mechanisms with enhanced precision. These developments underscore the importance of exploring mitochondrial regulatory mechanisms within the context of specific brain diseases. However, the delivery of mitochondria-targeted therapies across the blood-brain barrier (BBB) remains a clinical obstacle, necessitating comprehensive investigations into the BBB's impact on these therapies. Herein, we systematically examine the diverse phenotypes and functional plasticity of mitochondria in the regulatory mechanisms of brain diseases. We also delve into the novel insights provided by nano-targeted therapies, emphasizing the interplay between mitochondria and oxidative stress across various etiologies and disease features, particularly in gliomas, neurodegenerative diseases, ischemic stroke, and acute brain injuries. Additionally, we highlight preclinical and clinical mitochondrial-targeting strategies and discuss their translational implications.

Förderung

  • Natural Science Foundation of Beijing Municipality
  • Beijing Natural Science Foundation
  • National Natural Science Foundation of China
  • Jilin Provincial Natural Science Foundation
  • Natural Science Foundation of Shandong Province
  • China Postdoctoral Science Foundation

Zitieren

APA

Liao, J., He, W., Li, L., Wang, J., Gong, L., Zhang, Q., & Lin, Z. (2025). Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies. Cell Biomaterials, 1(2), 100016. https://doi.org/10.1016/j.celbio.2025.100016

Vancouver

Liao J, He W, Li L, Wang J, Gong L, Zhang Q, et al. Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies. Cell Biomaterials. 2025;1(2):100016. doi:10.1016/j.celbio.2025.100016

BibTeX
@article{Liao2025,
  author = {Liao, Jun and He, Wenxiu and Li, Lisha and Wang, Jingya and Gong, Lidong and Zhang, Qiang and Lin, Zhiqiang},
  title = {Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies},
  journal = {Cell Biomaterials},
  year = {2025},
  volume = {1},
  number = {2},
  pages = {100016},
  doi = {10.1016/j.celbio.2025.100016}
}
Kostenlos starten →